dr. mohamad aimanuddin bin mohtar

pensyarah universiti

institut perubatan molekul (umbi)

No. rasmi:
UKM : 03 8921 5555



   Biografi/ Biography :

  • M. Aiman Mohtar is a Research Fellow at the UKM Medical Molecular Biology Institute (UMBI), The National University of Malaysia. He previously earned his BSc. (Biotechnology) with highest honours from Rochester Institute of Technology, New York and MSc. (Molecular Biology) from University of Pennsylvania, Philadelphia. He completed his PhD in Molecular and Clinical Medicine at Institute of Genetics and Molecular Medicine, University of Edinburgh. His PhD thesis focuses on identification of protein-protein interaction network of an oncogenic ER-resident protein. He has been trained as molecular biologist for more than a decade and has involved in research utilizing cutting- edge laboratory techniques such as CRISPR-Cas9 gene editing tools, fluorescence microscopy, phage display and quantitative proteomics. Aiman’s current research focus is studying protein-protein interaction and tumour cell secretory addiction in AGR2 signalling axis using multi-omics approach and developing therapeutic tools targeting pro-oncogenic molecules.

  • asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    asmaa y. abuhamad, ling sheen, safaa m. naes, siti nur hasanah yusuf, nurul nadia zamberi, asilah ahmad tajudin, mohamad aimanuddin mohtar, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2022).  crispr gene editing: the generation ooff genetically engineered breast cancer cells for interrogating the l194f p53 mutation.  - malaysian journal of medicine and health sciences.  46. 

     

    nisa syakila a rahman, teck yew low, saiful effendi syafruddin, m. aiman mohtar.  (2021).  functional interrogation of crispr-cas9 mediated agr2 knockout in metastatic triple negative breast cancer cells.  - asm science journal.  91. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    teck yew low, m. aiman mohtar, pey yee lee, nursyazwani omar, houjiang zhou, mingliang ye.  (2021).  widening the bottleneck of phosphoproteomics: evolving strategies for phosphopeptide enrichment.  - mass spectrometry reviews.  309-333. 

     

    teck yew low, saiful effendi syafruddin, m. aiman mohtar, adaikkalam vellaichamy, nisa syakila a rahman, yuh-fen pung & chris soon heng tan.  (2021).  recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions.  - cellular and molecular life sciences.  5325-5339. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, wan fahmi wan mohamad nazarie, nurshahirah ashikin moidu, bee hong soon, m. aiman mohtar.  (2021).  integration of rna-seq and proteomics data identifies glioblastoma multiforme surfaceome signature.  - bmc cancer.  1-13. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    asmaa y. i. abuhamad, mohamad aimanuddin mohtar, asilah ahmad tajudin, amir syahir amir hamzah, saiful effendi syafruddin.  (2021).  crispr-mediated generation of in vitro breast cancer models to study p53 gain of function mutation.  - asia pacific journal of molecular biology & biotechnology.  1. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;siti nurmi binti nasir;low teck yew.  (2021).  devising synthetic anti-cancer tools targeting pro-oncogenic agr2 protein.  -

     

    nadiah binti abu;a. rahman bin a. jamal;fuad bin ismail;luqman bin mazlan;nurul syakima binti ab mutalib;mohamad aimanuddin bin mohtar.  (2021).  understanding the effects of chemotherapy-induced exosomes (chemoexosomes) on human t cells subsets .  -

     

    asmaa y. abuhamad, ling sheen, safaa m. naes, siti nur hasanah yusuf, nurul nadia zamberi, asilah ahmad tajudin, mohamad aimanuddin mohtar, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr gene editing the generation of genetically engineered breast cancer cells for interrogating the l194f p53 mutation.  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14. 

     

    asmaa y. i. abuhamad, mohamad aimanuddin mohtar, asilah ahmad tajudin, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr-mediated generation of in vitro breast cancer models to study p53 ain-of-function mutation.  - 4th international conference on molecular biology & biotechnology.  1-19. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar and saiful effendi syafruddin.  (2021).  pdgfb paracrine signalling fuels growth promoting mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14. 

     
    dr. mohamad aimanuddin bin mohtar

    pensyarah universiti

    institut biologi molekul perubatan ukm (umbi)

     m.aimanmohtar@ppukm.ukm.edu.my

    No. sambungan :  9062

    No. rasmi:
    UKM : 03 8921 5555



       Biografi/ Biography :

  • PENSYARAH UNIVERSITI

  • asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    asmaa y. abuhamad, ling sheen, safaa m. naes, siti nur hasanah yusuf, nurul nadia zamberi, asilah ahmad tajudin, mohamad aimanuddin mohtar, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2022).  crispr gene editing: the generation ooff genetically engineered breast cancer cells for interrogating the l194f p53 mutation.  - malaysian journal of medicine and health sciences.  46. 

     

    nisa syakila a rahman, teck yew low, saiful effendi syafruddin, m. aiman mohtar.  (2021).  functional interrogation of crispr-cas9 mediated agr2 knockout in metastatic triple negative breast cancer cells.  - asm science journal.  91. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    teck yew low, m. aiman mohtar, pey yee lee, nursyazwani omar, houjiang zhou, mingliang ye.  (2021).  widening the bottleneck of phosphoproteomics: evolving strategies for phosphopeptide enrichment.  - mass spectrometry reviews.  309-333. 

     

    teck yew low, saiful effendi syafruddin, m. aiman mohtar, adaikkalam vellaichamy, nisa syakila a rahman, yuh-fen pung & chris soon heng tan.  (2021).  recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions.  - cellular and molecular life sciences.  5325-5339. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, wan fahmi wan mohamad nazarie, nurshahirah ashikin moidu, bee hong soon, m. aiman mohtar.  (2021).  integration of rna-seq and proteomics data identifies glioblastoma multiforme surfaceome signature.  - bmc cancer.  1-13. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    asmaa y. i. abuhamad, mohamad aimanuddin mohtar, asilah ahmad tajudin, amir syahir amir hamzah, saiful effendi syafruddin.  (2021).  crispr-mediated generation of in vitro breast cancer models to study p53 gain of function mutation.  - asia pacific journal of molecular biology & biotechnology.  1. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;siti nurmi binti nasir;low teck yew.  (2021).  devising synthetic anti-cancer tools targeting pro-oncogenic agr2 protein.  -

     

    nadiah binti abu;a. rahman bin a. jamal;fuad bin ismail;luqman bin mazlan;nurul syakima binti ab mutalib;mohamad aimanuddin bin mohtar.  (2021).  understanding the effects of chemotherapy-induced exosomes (chemoexosomes) on human t cells subsets .  -

     

    asmaa y. abuhamad, ling sheen, safaa m. naes, siti nur hasanah yusuf, nurul nadia zamberi, asilah ahmad tajudin, mohamad aimanuddin mohtar, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr gene editing the generation of genetically engineered breast cancer cells for interrogating the l194f p53 mutation.  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14. 

     

    asmaa y. i. abuhamad, mohamad aimanuddin mohtar, asilah ahmad tajudin, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr-mediated generation of in vitro breast cancer models to study p53 ain-of-function mutation.  - 4th international conference on molecular biology & biotechnology.  1-19. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar and saiful effendi syafruddin.  (2021).  pdgfb paracrine signalling fuels growth promoting mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14.